B. Riley Securities analyst Craig Ellis downgrades Semtech (NASDAQ:SMTC) from Buy to Neutral and lowers the price target from $87 to $65.
What Does Chemours Debt Look Like?
Shares of Chemours (NYSE:CC) fell by 6.6% on Thursday. Before having a look at the importance of debt, let us look at how much debt Chemours has.